Cell death’s hidden diversity: How biomedical reductionism obscures systemic healing pathways
Original framing: “All the ways a cell can die — and why the variety matters” — Nature
Marginalized communities, particularly in the Global South, experience cell death-related diseases (e.g., autoimmune disorders) as symptoms of colonial health legacies. For example, Indigenous Australians have higher rates of rheumatoid arthritis, linked to disrupted land stewardship and dietary shifts imposed by colonization. Patient advocacy groups in Latin America highlight how biotech patents on cell death modulators (e.g., *ferroptosis* inhibitors) prioritize profit over accessible treatments, reinforcing health inequities. These voices are absent from narratives that frame cell death as a neutral scientific curiosity.
The original framing treats cell death as a scientific puzzle to be solved, but the systemic reality reveals it as a site of colonial erasure, cultural wisdom, and ecological feedback.
Indigenous and traditional systems have long understood cell death as relational—tied to land, ancestry, and ritual—yet these perspectives were suppressed to legitimize Western biomedical reductionism. The 'variety' of cell death pathways is not just a scientific curiosity but a reflection of evolutionary trade-offs shaped by environmental pressures, from agrochemicals to ultra-processed diets, which disproportionately affect marginalized communities. Solutions must move beyond drug-centric approaches to integrate Indigenous data sovereignty, metabolic-ecological health models, and psychedelic-assisted therapies, while dismantling the power structures that have historically treated cell death as a problem to exploit rather than a process to understand holistically.